Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis

Journal of Virology

Volumn 76, Issue 20, 2002, Pages 10437-10443

  Rooney, C P ^a   Denning, G M ^a   Davis, B P ^a   Flaherty, D M ^a   Chiorini, J A ^a   Zabner, J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BETA GALACTOSIDASE; GLYCOSYLPHOSPHATIDYLINOSITOL; IMMUNOGLOBULIN; NEUTRALIZING ANTIBODY; VIRUS RECEPTOR; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS; CYSTIC FIBROSIS; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; LUNG LAVAGE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY EPITHELIUM;

ADENOVIRUSES, HUMAN; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; CYSTIC FIBROSIS; DEPENDOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LUNG; NEUTRALIZATION TESTS; RECEPTORS, VIRUS; RESPIRATORY MUCOSA; TRACHEA;

EID: 0036786467     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.20.10437-10443.2002     Document Type: Article

References (56)

1. Alisky, J. M., S. M. Hughes, S. L. Sauter, D. Jolly, T. W. Dubensky, Jr., P. D. Staber, J. A. Chiorini, and B. L. Davidson. 2000. Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Neuroreport 11:2669-2673.
2. Bainbridge, T., and R. B. Fick, Jr. 1989. Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase. J. Lab. Clin. Med. 114:728-733.
3. Bals, R., W. Xiao, N. Sang, D. J. Weiner, R. L. Meegalla, and J. M. Wilson. 1999. Transduction of well-differentiated airway epithelium by recombinant adeno-associated virus is limited by vector entry. J. Virol. 73:6085-6088.
4. Bastian, A., and B. Bewig. 1999. Inhibition of adenovirus-mediated gene transfer by bronchoalveolar lavage fluid. Gene Ther. 6:637-642.
5. Buret, A., and A. W. Cripps. 1993. The immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis. Am. Rev. Respir. Dis. 148: 793-805.
6. Casolaro, M. A., G. Fells, M. Wewers, J. E. Pierce, F. Ogushi, R. Hubbard, S. Sellers, J. Forstrom, D. Lyons, G. Kawasaki, et al. 1987. Augmentation of lung antineutrophil elastase capacity with recombinant human alpha-1-antitrypsin. J. Appl. Physiol. 63:2015-2023.
7. Chirmule, N., K. Propert, S. Magosin, Y. Qian, R. Qian, and J. Wilson. 1999. Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther. 6:1574-1583.
8. Chu, Q., J. A. St. George, M. Lukason, S. H. Cheng, R. K. Scheule, and S. J. Eastman. 2001. EGTA enhancement of adenovirus-mediated gene transfer to mouse tracheal epithelium in vivo. Hum. Gene Ther. 12:455-467.
9. Cox, C. D. 1986. Role of pyocyanin in the acquisition of iron from transferrin. Infect. Immun. 52:263-270.
10. Crystal, R. G., M. L. Brantly, R. C. Hubbard, D. T. Curiel, D. J. States, and M. D. Holmes. 1989. The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy. Chest 95:196-208.
11. Curiel, D. T., J. M. Pilewski, and S. M. Albelda. 1996. Gene therapy approaches for inherited and acquired lung diseases. Am. J. Respir. Cell Mol. Biol. 14:1-18.
12. Denning, G. M., M. A. Railsback, G. T. Rasmussen, C. D. Cox, and B. E. Britigan. 1998. Pseudomonas pyocyanine alters calcium signaling in human airway epithelial cells. Am. J. Physiol. 274:L893-L900.
13. Denning, G. M., L. A. Wollenweber, M. A. Railsback, C. D. Cox, L. L. Stoll, and B. E. Britigan. 1998. Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells. Infect. Immun. 66:5777-5784.
14. Doring, G., F. Frank, C. Boudier, S. Herbert, B. Fleischer, and G. Bellon. 1995. Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis. J. Immunol. 154:4842-4850.
15. Drapkin, P. T., C. R. O'Riordan, S. M. Yi, J. A. Chiorini, J. Cardella, J. Zabner, and M. J. Welsh. 2000. Targeting the urokinase plasminogen activator receptor enhances gene transfer to human airway epithelium. J. Clin. Investig. 105:589-596.
16. Duan, D., Y. Yue, Z. Yan, P. B. McCray, and J. F. Engelhardt. 1998. Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelium. Hum. Gene Ther. 9:2761-2776.
17. Flaherty, D. M., M. M. Monick, A. B. Carter, M. W. Peterson, and G. W. Hunninghake. 2001. GM-CSF increases AP-1 DNA binding and Ref-1 amounts in human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 25:254-259.
18. Gahery-Segard, H., V. Molinier-Frenkel, C. Le Boulaire, P. Saulnier, P. Opolon, R. Lengagne, E. Gautier, A. Le Cesne, L. Zitvogel, A. Venet, C. Schatz, M. Courtney, T. Le Chevalier, T. Tursz, J. G. Guillet, and F. Farace. 1997. Phase 1 trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products. J. Clin. Investig. 100:2218-2226.
19. Grubb, B. R., R. J. Pickles, H. Ye, J. R. Yankaskas, R. N. Vick, J. F. Engelhardt, J. M. Wilson, L. G. Johnson, and R. C. J. Boucher. 1994. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelium of mice and humans. Nature 371:802-806.
20. Harvey, B. G., P. L. Leopold, N. R. Hackett, T. M. Grasso, P. M. Williams, A. L. Tucker, R. J. Kaner, B. Ferris, I. Gonda, T. D. Sweeney, R. Ramalingam, I. Kovesdi, S. Shak, and R. G. Crystal. 1999. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J. Clin. Investig. 104:1245-1255.
21. Heck, L. W., P. G. Alarcon, R. M. Kulhavy, K. Morihara, M. W. Russell, and J. F. Mestecky. 1990. Degradation of IgA proteins by Pseudomonas aeruginosa elastase. J. Immunol. 144:2253-2257.
22. Hildinger, M., A. Auricchio, G. Gao, L. Wang, N. Chirmule, and J. M. Wilson. 2001. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J. Virol. 75:6199-6203.
23. Holder, I. A., and R. Wheeler. 1984. Experimental studies of the pathogenesis of infections owing to Pseudomonas aeruginosa: elastase, an IgG protease. Can. J. Microbiol. 30:1118-1124.
24. Kanthakumar, K., G. Taylor, K. W. T. Tsang, D. R. Cundell, A. Rutman, S. Smith, P. K. Jeffery, P. J. Cole, and R. Wilson. 1993. Mechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro. Infect. Immun. 61:2848-2853.
25. Kaplan, J. M., J. A. St. George, S. E. Pennington, L. D. Keyes, R. P. Johnson, S. C. Wadsworth, and A. E. Smith. 1996. Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2. Gene Ther. 3:117-127.
26. Kondo, M., W. E. Finkbeiner, and J. H. Widdicombe. 1991. Simple technique for culture of highly differentiated cells from dog tracheal epithelium. Am. J. Physiol. 261:L106-L117.
27. Konstan, M. W., K. A. Hilliard, T. M. Norvell, and M. Berger. 1994. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am. J. Respir. Crit. Care Med. 150:448-454.
28. McElvaney, N. G., H. Nakamura, P. Birrer, C. A. Hebert, W. L. Wong, M. Alphonso, J. B. Baker, M. A. Catalano, and R. G. Crystal. 1992. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J. Clin. Investig. 90:1296-1301.
29. McNeely, T. B., M. Dealy, D. J. Dripps, J. M. Orenstein, S. P. Eisenberg, and S. M. Wahl. 1995. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J. Clin. Investig. 96:456-464.
30. McNeely, T. B., D. C. Shugars, M. Rosendahl, C. Tucker, S. P. Eisenberg, and S. M. Wahl. 1997. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood 90:1141-1149.
31. Parmely, M., A. Gale, M. Clabaugh, R. Horvat, and W. W. Zhou. 1990. Proteolytic inactivation of cytokines by Pseudomonas aeruginosa. Infect. Immun. 58:3009-3014.
32. Perricone, M. A., D. D. Rees, C. R. Sacks, K. A. Smith, J. M. Kaplan, and J. A. St. George. 2000. Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells. Hum. Gene Ther. 11:1997-2008.
33. Pickles, R. J., D. McCarty, H. Matsui, P. J. Hart, S. H. Randell, and R. C. Boucher. 1998. Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J. Virol. 72: 6014-6023.
34. Rosenecker, J., K. H. Harms, R. M. Bertele, A. Pohl-Koppe, E. von Mutius, D. Adam, and T. Nicolai. 1996. Adenovirus infection in cystic fibrosis patients: implications for the use of adenovirus vectors for gene transfer. Infection 24:5-8.
35. Rutledge, E. A., C. L. Halbert, and D. W. Russell. 1998. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J. Virol. 72:309-319.
36. Sagel, S. D., R. Kapsner, I. Osberg, M. K. Sontag, and F. J. Accurso. 2001. Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. Am. J. Respir. Crit. Care Med. 164:1425-1431.
37. Stern, M., N. J. Caplen, J. E. Browning, U. Griesenbach, F. Sorgi, L. Huang, D. C. Gruenert, C. Marriot, R. G. Crystal, D. M. Geddes, and E. W. Alton. 1998. The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro. Gene Ther. 5:91-98.
38. Thompson, A. B., T. Bohling, F. Payvandi, and S. I. Rennard. 1990. Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J. Lab. Clin. Med. 115: 148-158.
39. Travis, S. M., B. A. Conway, J. Zabner, J. J. Smith, N. N. Anderson, P. K. Singh, E. P. Greenberg, and M. J. Welsh. 1999. Activity of abundant antimicrobials of the human airway. Am. J. Respir. Cell Mol. Biol. 20:872-879.
40. van't Hof, W., and R. G. Crystal. 2001. Manipulation of the cytoplasmic and transmembrane domains alters the cell surface levels of the coxsackie-adenovirus receptor and changes the efficiency of adenovirus infection. Hum. Gene Ther. 12:25-34.
41. Virella-Lowell, I., A. Poirier, K. A. Chesnut, M. Brantly, and T. R. Flotte. 2000. Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients. Gene Ther. 7:1783-1789.
42. Vogelmeier, C., R. C. Hubbard, G. A. Fells, H. P. Schnebli, R. C. Thompson, H. Fritz, and R. G. Crystal. 1991. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J. Clin. Investig. 87:482-488.
43. Walters, R. W., T. Grunst, J. M. Bergelson, R. W. Finberg, M. J. Welsh, and J. Zabner. 1999. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelium. J. Biol. Chem. 274: 10219-10226.
44. Walters, R. W., W. van't Hof, S. M. P. Yi, M. K. Schroth, J. Zabner, R. G. Crystal, and M. J. Welsh. 2001. Apical localization of the coxsackie-adenovirus receptor by glycosyl-phosphatidylinositol modification is sufficient for adenovirus-mediated gene transfer through the apical surface of human airway epithelia. J. Virol. 75:7703-7711.
45. Walters, R. W., S. M. Yi, S. Keshavjee, K. E. Brown, M. J. Welsh, J. A. Chiorini, and J. Zabner. 2001. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 276:20610-20616.
46. Wang, X., and J. M. Bergelson. 1999. Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirus infection. J. Virol. 73:2559-2562.
47. Welsh, M. J. 1999. Gene transfer for cystic fibrosis. J. Clin. Investig. 104: 1165-1166.
48. West, J., and D. M. Rodman. 2001. Gene therapy for pulmonary diseases. Chest 119:613-617.
49. Wickham, T. J. 2000. Targeting adenovirus. Gene Ther. 7:110-114.
50. Wilson, R., and R. B. Dowling. 1998. Lung infections. 3. Pseudomonas aeruginosa and other related species. Thorax 53:213-219.
51. Xiao, W., N. Chirmule, S. C. Berta, B. McCullough, G. Gao, and J. M. Wilson. 1999. Gene therapy vectors based on adeno-associated virus type 1. J. Virol. 73:3994-4003.
52. Yang, Y., G. Trinchieri, and J. M. Wilson. 1995. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1:890-893.
53. Zabner, J., P. Freimuth, A. Puga, A. Fabrega, and M. J. Welsh. 1997. Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelium to adenovirus infection. J. Clin. Investig. 100:1144-1149.
54. Zabner, J., B. W. Ramsey, D. P. Meeker, M. I. Aitken, R. P. Balfour, R. L. Gibson, J. Launspach, R. A. Moscicki, S. M. Richards, T. A. Standaert, J. Williams-Warren, S. C. Wadsworth, A. E. Smith, and M. J. Welsh. 1996. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J. Clin. Investig. 97:1504-1511.
55. Zabner, J., M. Seiler, R. Walters, R. M. Kotin, W. Fulgeras, B. L. Davidson, and J. A. Chiorini. 2000. Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelium and facilitates gene transfer. J. Virol. 74:3852-3858.
56. Zabner, J., B. G. Zeiher, E. Friedman, and M. J. Welsh. 1996. Adenovirus-mediated gene transfer to ciliated airway epithelium requires prolonged incubation time. J. Virol. 70:6994-7003.